Propanc Biopharma, Inc. (OTCMKTS:PPCB) Sees Large Increase in Short Interest

Propanc Biopharma, Inc. (OTCMKTS:PPCB) was the recipient of a significant growth in short interest in March. As of March 15th, there was short interest totalling 200 shares, a growth of 100.0% from the February 28th total of 100 shares. Based on an average daily trading volume, of 400 shares, the short-interest ratio is presently 0.5 days. Currently, 0.0% of the company’s stock are sold short.

Propanc Biopharma Price Performance

OTCMKTS PPCB traded down $0.43 during trading hours on Friday, hitting $5.25. The company’s stock had a trading volume of 116 shares, compared to its average volume of 415. Propanc Biopharma has a 52 week low of $2.76 and a 52 week high of $222.00. The company’s 50-day simple moving average is $6.64 and its two-hundred day simple moving average is $2.31.

About Propanc Biopharma

Propanc Biopharma, Inc, a biopharmaceutical company, develops cancer treatments for patients with pancreatic, ovarian, and colorectal cancer in Australia. It offers PRP, a formulation lead product that is in preclinical phase of development designed to enhance the anti-cancer effects of multiple enzymes.